Table of Contents
- What Is Ashwagandha and Why Are Researchers Studying It for Sleep?
- The 2021 Meta-Analysis: What 400 Participants Tell Us
- KSM-66 Sleep Research: The Most Studied Extract
- Ashwagandha Triethylene Glycol: The Sleep-Specific Compound
- What Sleep Outcomes Actually Improve?
- Ashwagandha and Cortisol: The Stress-Sleep Connection
- Insomnia vs. Healthy Sleepers: Who Benefits Most?
- Dosage and Duration: What the Clinical Research Recommends
- Safety Profile and Side Effects
- Ongoing Research and What We Still Don't Know
- Frequently Asked Questions
- Bottom Line
What Is Ashwagandha and Why Are Researchers Studying It for Sleep?
If you've spent any time browsing supplement aisles or wellness blogs, you've almost certainly encountered ashwagandha. But what separates this particular herb from the crowd of overhyped botanicals is something specific: a growing body of controlled clinical research that is actually measuring its effects on sleep with the same tools researchers use to evaluate pharmaceutical sleep aids.
Ashwagandha — formally known as Withania somnifera — is a small shrub native to India, North Africa, and the Mediterranean. Its root has been used in Ayurvedic medicine for more than 3,000 years, primarily as an adaptogen: a substance thought to help the body resist physical and mental stress. The Latin species name somnifera literally means "sleep-inducing," which tells you something about how this plant has historically been understood.
Modern scientists have become interested in ashwagandha sleep improvement for several interrelated reasons. First, the herb contains a unique profile of bioactive compounds — including withanolides, alkaloids, and most notably a compound called triethylene glycol — that appear to act on specific neurological pathways involved in sleep regulation. Second, because stress and sleep are deeply intertwined physiologically, an adaptogen that measurably reduces stress hormones like cortisol might plausibly improve sleep as a downstream effect. Third, prescription sleep medications come with significant baggage: dependence risk, tolerance, cognitive side effects, and withdrawal. Researchers and clinicians are genuinely motivated to find alternatives.
This post synthesizes the clinical research on Withania somnifera sleep outcomes as of 2025, including the landmark 2021 PLOS One meta-analysis, findings from randomized controlled trials, and what the National Institutes of Health's Office of Dietary Supplements has concluded from its review of the evidence. We'll look at what improves, by how much, in whom, and at what dose — and we'll be equally clear about what the research hasn't yet established.
Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.
Try our new organic cortisol balance drops risk free
Shop Organic Cortisol Balance Drops
The 2021 Meta-Analysis: What 400 Participants Tell Us
The most rigorously designed summary of ashwagandha sleep quality clinical research to date is a 2021 meta-analysis published in PLOS One — one of the peer-reviewed journals consistently cited by major health institutions, including the NIH's Office of Dietary Supplements, when summarizing the evidence base for this herb.
The Study Design
The researchers pooled data from five randomized controlled trials (RCTs) involving a total of 400 participants. RCTs are the methodological gold standard in clinical research because they use random assignment to treatment or placebo groups, which controls for confounding variables and reduces the chance that observed effects are due to anything other than the intervention itself. The inclusion of five separate RCTs, rather than relying on a single trial, adds confidence that any observed effects are reproducible across different populations and study conditions.
The Primary Finding
The pooled analysis found a statistically significant improvement in overall sleep quality in the ashwagandha groups compared to placebo, with a standardized mean difference (SMD) of -0.59 (95% confidence interval: -0.75 to -0.42), a heterogeneity value of I² = 62%, and a p-value of less than 0.001.
For readers unfamiliar with these statistics, here's what they mean in plain language:
- SMD of -0.59: This represents a moderate effect size. In sleep research, an SMD in this range is clinically meaningful — it's roughly comparable to effects seen with some behavioral sleep interventions. An SMD below -0.2 is considered small; -0.5 is medium; -0.8 is large.
- 95% CI of -0.75 to -0.42: The entire confidence interval falls below zero, meaning we can be 95% confident the true effect is in the direction of improvement, not just statistical noise.
- p < 0.001: The probability that this result is due to random chance is less than 0.1%.
- I² = 62%: This indicates moderate-to-high heterogeneity between studies, meaning the trials weren't identical in design, population, or dosing. This is worth noting — it suggests the effect size may vary depending on who is taking ashwagandha and how.
Subgroup Findings
Some of the most important findings from this meta-analysis come from the subgroup analyses, which examined whether certain conditions amplified the effect:
People with diagnosed insomnia showed stronger improvements than healthy sleepers without sleep disorders. This is a recurring theme across ashwagandha sleep research and has significant implications for who is most likely to benefit.
Doses of ≥600 mg/day produced larger effects than lower doses. Most of the included trials used 600 mg of root extract daily, split into one or two doses.
Duration of ≥8 weeks was associated with greater improvements than shorter trials. This suggests ashwagandha is not an acute sleep aid in the way that melatonin or a pharmaceutical hypnotic might be — it appears to work gradually, potentially by addressing underlying physiological factors rather than triggering sleep directly.
Limitations Acknowledged
The authors of the meta-analysis themselves noted that while the findings are encouraging, the total number of trials and participants remains limited. Larger, longer-duration RCTs are needed to confirm the magnitude of effect and to identify which subpopulations benefit most. The moderate-to-high heterogeneity (I² = 62%) also means these results should be interpreted with some caution rather than treated as a definitive answer.
KSM-66 Sleep Research: The Most Studied Extract
Not all ashwagandha supplements are the same, and nowhere is this more apparent than in the clinical literature. A disproportionate share of high-quality ashwagandha sleep studies have used a specific standardized root extract called KSM-66, manufactured by Ixoreal Biomed and characterized by a consistent withanolide content of at least 5%.
Why Standardization Matters
Raw ashwagandha root and loosely standardized powders vary enormously in their concentration of active compounds. When a researcher studies "ashwagandha," the results are only reliable and reproducible if the extract used in one study contains roughly the same active compounds as the extract used in another. KSM-66's consistent chemical fingerprint has made it the preferred choice for researchers who need reproducibility.
KSM-66 Sleep Study Results: What the Trials Found
The KSM-66 sleep research body includes multiple double-blind, placebo-controlled trials. One frequently cited study — a randomized controlled trial published around 2020–2021 — examined the effects of KSM-66 ashwagandha extract on sleep parameters in both healthy adults and individuals with insomnia disorder. The results showed significant improvements in multiple sleep metrics:
- Sleep quality scores (measured by validated questionnaires including the Pittsburgh Sleep Quality Index, or PSQI) improved significantly in the treatment group compared to placebo
- Sleep efficiency — the proportion of time in bed actually spent asleep — increased
- Total sleep time increased
- Sleep onset latency (how long it takes to fall asleep) decreased
- Wake after sleep onset (how often participants woke up during the night) decreased
Critically, the extract was described as well tolerated, with no serious adverse events reported in the trial population.
KSM-66 Sleep Study Results in Numbers
Across several double-blind, placebo-controlled trials, improvements in sleep quality have been reported in the range of 30–72% compared to baseline, with larger gains generally seen in participants who had pre-existing sleep disturbances. These figures represent self-reported or questionnaire-based sleep quality scores and should be understood as subjective measures, though they align with the more objective findings from polysomnography-based research.
The KSM-66 sleep study results have been consistent enough that the NIH's Office of Dietary Supplements — not an organization known for enthusiastically endorsing supplements — has acknowledged that clinical trials found potential improvements in sleep quality, efficiency, total sleep time, and sleep latency, with more prominent effects at 600 mg/day for at least 8 weeks.
Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.
Try our new organic cortisol balance drops risk free
Shop Organic Cortisol Balance DropsAshwagandha Triethylene Glycol: The Sleep-Specific Compound
One of the more fascinating recent developments in ashwagandha sleep quality clinical research is the identification of a specific compound within the plant that appears to be responsible — at least in part — for its sleep-promoting properties. That compound is triethylene glycol (TEG).
What Is Triethylene Glycol?
Triethylene glycol is a small-molecule alcohol found in ashwagandha leaf extract. Unlike the withanolides, which are the compounds most associated with ashwagandha's adaptogenic and anti-inflammatory effects, triethylene glycol has been shown in preclinical studies to specifically induce non-rapid eye movement (NREM) sleep, which includes the deep, restorative slow-wave sleep stages.
The Ashwagandha Triethylene Glycol Sleep Research
Research published in PLOS One identified TEG as a key active constituent for sleep induction in mice, noting that it significantly increased NREM sleep time while having minimal effect on REM sleep. This mechanistic specificity is notable: it suggests ashwagandha doesn't simply sedate broadly (as benzodiazepines do, for example) but may selectively promote the deeper, slow-wave sleep phases that are most associated with physical recovery, immune function, and cognitive consolidation.
The clinical implication of the ashwagandha triethylene glycol sleep research is significant. It provides a plausible biochemical explanation for why human clinical trials see improvements in sleep quality rather than just sedation — and it raises the possibility that future ashwagandha formulations might be optimized specifically for TEG content to maximize sleep benefits.
It's worth noting that most commercially available ashwagandha supplements are root extracts, and TEG appears to be found primarily in the leaves. The relationship between leaf- and root-derived extracts in terms of TEG content, and how this affects clinical sleep outcomes, remains an area where more human data is needed.
Withanolides and Sleep: A Supporting Role
Separate from TEG, the withanolide compounds — particularly withanolide A — appear to influence GABAergic neurotransmission, the same neurological pathway targeted by benzodiazepines and many prescription sleep medications. However, ashwagandha's interaction with GABA receptors appears to be partial and modulatory rather than strongly agonistic, which may explain why it lacks the sedative side effects and dependence potential of pharmaceutical GABA agonists.
What Sleep Outcomes Actually Improve?
A key question for anyone evaluating this research is: what specifically gets better? "Sleep quality" is a broad and somewhat subjective term. The clinical literature on ashwagandha sleep improvement has used validated instruments and, in some cases, objective measures to track multiple distinct outcomes.
Sleep Quality (Subjective)
The Pittsburgh Sleep Quality Index (PSQI) is the most commonly used validated questionnaire in these studies. It captures seven components of sleep including subjective quality, sleep latency, duration, efficiency, disturbances, use of sleep medications, and daytime dysfunction. Multiple trials have shown significant PSQI improvements in ashwagandha-treated subjects compared to placebo, with the most consistent gains in people with baseline sleep problems.
Sleep Onset Latency
Ashwagandha sleep onset research has consistently found reductions in the time it takes participants to fall asleep. This is one of the most clinically relevant outcomes for people with insomnia, for whom prolonged pre-sleep wakefulness is both a symptom and a source of anxiety that perpetuates the condition. The reduction in sleep onset latency observed in trials isn't dramatic in absolute terms — we're typically talking about reductions of 10–20 minutes compared to placebo — but this is meaningful for chronic insomnia sufferers.
Total Sleep Time
Several trials have reported modest but statistically significant increases in total sleep time in the ashwagandha groups. Again, these are generally not dramatic changes (not hours of additional sleep), but consistent small improvements across multiple trials add up to a meaningful signal.
Sleep Efficiency
Sleep efficiency — defined as the ratio of total sleep time to total time spent in bed — improved in multiple trials. This measure captures how "consolidated" sleep is, and improvements here are associated with better daytime functioning and reduced sleep-related frustration.
Ashwagandha Deep Sleep
The ashwagandha deep sleep question is perhaps the most intriguing from a mechanistic standpoint. The triethylene glycol research specifically points toward NREM slow-wave sleep enhancement. A small number of studies using polysomnography (objective sleep monitoring) have suggested improvements in slow-wave sleep, but this area needs more large-scale human data to draw firm conclusions.
Daytime Functioning
Beyond nighttime outcomes, several trials also measured daytime effects. Participants receiving ashwagandha reported lower levels of daytime sleepiness, better mental alertness, and improved quality of life scores — outcomes consistent with genuinely better nighttime sleep rather than a simple sedative effect that might actually worsen daytime cognition.
Ashwagandha and Cortisol: The Stress-Sleep Connection
Understanding the relationship between ashwagandha cortisol sleep dynamics may be the most important key to understanding why this herb improves sleep at all — and why it seems to work better over weeks than days.
How Elevated Cortisol Disrupts Sleep
Cortisol is the body's primary stress hormone, produced by the adrenal glands under direction from the hypothalamic-pituitary-adrenal (HPA) axis. In a healthy circadian rhythm, cortisol levels peak sharply in the morning (the "cortisol awakening response," which promotes alertness and energy) and decline steadily throughout the day, reaching their lowest point around midnight to 2 AM, allowing sleep to deepen.
When chronic stress disrupts this pattern — keeping cortisol elevated in the evening — the consequences for sleep are severe. Elevated evening cortisol increases sleep onset latency, reduces slow-wave sleep, promotes lighter sleep stages, increases nocturnal awakenings, and can contribute to the anxious pre-sleep mental activity that characterizes many cases of insomnia.
Ashwagandha's Cortisol-Lowering Effects
Multiple clinical trials — including some focused specifically on sleep — have measured cortisol levels in participants taking ashwagandha and found significant reductions compared to placebo. In one frequently cited trial, 600 mg/day of KSM-66 ashwagandha for 60 days reduced serum cortisol levels by approximately 27–30% compared to baseline in stressed adults.
This cortisol reduction appears to be the primary mechanism through which ashwagandha cortisol sleep improvement operates. Rather than acting directly as a sedative, ashwagandha appears to address the upstream physiological driver of sleep disruption in stressed individuals — normalizing the cortisol curve so that evening and nighttime levels are lower, allowing the brain's sleep systems to function more effectively.
Why This Explains the Time Course
This mechanism also explains why the research consistently shows greater benefits at ≥8 weeks of use compared to shorter durations. Correcting HPA axis dysregulation takes time. The cortisol system adapts gradually, which means ashwagandha users shouldn't expect to take a capsule tonight and sleep dramatically better tomorrow. The clinical evidence suggests a gradual, cumulative improvement over weeks — which is exactly what you'd predict from a mechanism involving hormonal rebalancing rather than acute sedation.
The Anxiety Connection
Relatedly, ashwagandha has substantial evidence for anxiolytic (anxiety-reducing) effects, which further supports its sleep benefits. Anxiety and insomnia are frequently comorbid — each worsening the other in a reinforcing cycle. Several trials have measured both anxiety and sleep as outcomes and found improvements in both, consistent with a mechanism that involves broadly reducing the physiological and psychological stress response.
Insomnia vs. Healthy Sleepers: Who Benefits Most?
This is one of the most practically important questions for potential users, and the clinical literature offers a fairly consistent answer.
Stronger Effects in People With Insomnia
The ashwagandha insomnia clinical trial literature shows clearly that people with pre-existing sleep disorders benefit more than healthy sleepers with no sleep complaints. This finding was explicit in the 2021 PLOS One meta-analysis (where it appeared as a significant subgroup difference) and has been replicated across individual trials.
The 2020/2021 randomized controlled trial that compared effects in both healthy and insomnia subjects found that "improvement was greater in insomnia subjects" — a finding the researchers noted explicitly in their conclusions.
This pattern makes intuitive sense. If your sleep is already functioning well, there's less room for improvement. Ashwagandha doesn't appear to push sleep beyond normal — it corrects deficits rather than enhancing beyond baseline. For someone sleeping well, the effects may be subtle or imperceptible. For someone with chronic insomnia, elevated stress hormones, or anxiety-driven sleep disruption, the same intervention addresses real physiological dysfunction and produces measurable gains.
Benefits Are Still Present in Healthy Adults
This doesn't mean healthy people experience no benefit — several trials specifically in healthy adult populations without diagnosed insomnia have still found significant improvements in PSQI scores, sleep onset latency, and morning alertness. The effect is just smaller in absolute terms, and some individuals may notice little change.
An ongoing ClinicalTrials.gov registered study examining 700 mg/day ashwagandha in healthy college students — measuring sleep, stress, and food intake — may provide additional data on effects in younger healthy adults when its results are published, though outcome data were not yet available at the time of this writing.
People With Stress-Related Sleep Problems
A particularly well-suited population appears to be people who don't have diagnosable insomnia disorder but who have stress-related sleep disruption — difficulty falling asleep or staying asleep during high-stress periods, feeling wired but tired at bedtime, or poor sleep quality during demanding life circumstances. This population sits between "healthy sleepers" and "clinical insomnia" and likely experiences benefits closer to the insomnia end of the spectrum, given the cortisol-mediated mechanism.
Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.
Try our new organic cortisol balance drops risk free
Shop Organic Cortisol Balance DropsDosage and Duration: What the Clinical Research Recommends
One of the most actionable takeaways from the ashwagandha sleep quality clinical research is that dosage and duration both matter significantly — and the clinical data actually gives us reasonably specific guidance.
The 600 mg/Day Threshold
The dose that appears most consistently effective across ashwagandha sleep research is 600 mg/day of standardized root extract. This was the dose used in the majority of trials included in the 2021 meta-analysis, and both the NIH ODS fact sheet and multiple clinical reviews identify 600 mg/day as the level at which sleep benefits become most apparent.
Some trials have used lower doses (300 mg/day split into two doses, for example) with modest results, while a few have used higher doses up to 1,000–1,200 mg/day without demonstrating proportionally greater benefits. The current evidence suggests 600 mg/day is a reasonable target, though the dose-response relationship at the higher end needs more study.
Timing of the Dose
Clinical trials have used different dosing schedules — some dividing 600 mg into two 300 mg doses (morning and evening), others giving it as a single evening dose. There isn't yet definitive evidence that one approach is clearly superior, though mechanistically, an evening dose might be more relevant for immediate sleep benefits, while a morning-evening split may better support overall HPA axis regulation throughout the day.
The 8-Week Minimum
The ashwagandha sleep onset research and broader meta-analysis data consistently show that benefits are more pronounced at ≥8 weeks of continuous use compared to shorter treatment periods. Trials of 4–6 weeks do show improvements, but the magnitude is generally smaller.
This has practical implications: someone who tries ashwagandha for two weeks and notices little difference shouldn't necessarily conclude it doesn't work. The clinical evidence suggests giving it at least 8 weeks at an appropriate dose before evaluating efficacy.
Long-Term Use: What We Know and Don't Know
Most clinical trials have run for 8–12 weeks, which means we have reasonably good evidence for safety and efficacy in that window. Longer-term use data in human clinical trials is limited. Ashwagandha has a long history of use in traditional Ayurvedic medicine without documented patterns of serious harm, but this shouldn't substitute for clinical evidence, particularly regarding effects on hormone levels (including thyroid hormones, which some research suggests may be affected by long-term use) and any medication interactions.
Safety Profile and Side Effects
Any responsible review of withania somnifera sleep research must address safety alongside efficacy. The good news is that the clinical trial literature generally characterizes ashwagandha as well tolerated at doses used for sleep. The nuances are important to understand, however.
Common Side Effects
In clinical trials, side effects reported more frequently in ashwagandha groups than placebo groups have generally been mild and gastrointestinal in nature: nausea, stomach upset, loose stools, or diarrhea. These are more common at higher doses and often resolve with dose adjustment or taking the supplement with food.
Drowsiness is occasionally reported — which may be considered a feature rather than a bug when the goal is better sleep, but is relevant if ashwagandha is taken at times when alertness is needed.
Serious Concerns: Rare Liver Events
A small number of case reports have described liver injury (hepatotoxicity) potentially associated with ashwagandha use. These cases are rare, and causality isn't definitively established in all instances, but they are serious enough that the FDA and several international health agencies have issued safety communications. The risk appears to be low in healthy individuals taking standard doses, but anyone with pre-existing liver conditions should consult a physician before use, and any signs of jaundice, dark urine, or severe abdominal pain should prompt immediate medical attention and discontinuation.
Hormonal Effects
Ashwagandha can influence hormone levels, including thyroid hormones (T3 and T4 may increase), testosterone, and DHEA-S. For most people, these changes are within physiological normal ranges and not concerning. However:
- People with thyroid conditions (or taking thyroid medications) should consult their physician, as ashwagandha's potential thyroid-stimulating effects could complicate management
- Pregnant women should avoid ashwagandha, as it may stimulate uterine contractions — this is one of the clearer contraindications in the literature
- People with autoimmune conditions should exercise caution, as ashwagandha's immune-modulating properties could theoretically worsen autoimmune activity
Drug Interactions
Clinically relevant potential interactions include:
- Immunosuppressants: Ashwagandha's immune-stimulating properties may theoretically counteract immunosuppressive medications
- Thyroid medications: Potential additive effects on thyroid hormone levels
- Sedatives and CNS depressants: Possible additive sedative effects — use with caution alongside prescription sleep medications, benzodiazepines, or alcohol
- Diabetes medications: Some evidence suggests ashwagandha may lower blood sugar; additive effects with antidiabetic drugs may require monitoring
Bottom Line on Safety
At 600 mg/day for 8–12 weeks in healthy adults without the contraindications listed above, ashwagandha appears to have a reasonable safety profile based on current clinical trial data. The NIH ODS characterizes it as "possibly safe" for short-term use in these populations. Long-term safety data remains limited.
Ongoing Research and What We Still Don't Know
The body of ashwagandha sleep quality clinical research has grown substantially over the past decade, but important gaps remain.
Active Clinical Trials
A registered ClinicalTrials.gov study is examining 700 mg/day ashwagandha in healthy college students, measuring effects on sleep quality, stress, and food intake. This trial is notable because it focuses on a healthy young adult population and uses a slightly higher dose than most existing trials. Results, when published, could meaningfully add to our understanding of ashwagandha's effects in people without clinical sleep disorders.
Questions the Current Evidence Doesn't Fully Answer
Polysomnographic data: Most existing trials use subjective questionnaires (like the PSQI) as their primary outcome. Polysomnography — objective sleep stage monitoring — has been used in some studies and suggests benefits including slow-wave sleep enhancement, but this data is limited. Larger trials using objective sleep monitoring would significantly strengthen the evidence base.
Very long-term safety: Clinical trials longer than 12 weeks are rare. Given that many people interested in ashwagandha for sleep would want to use it indefinitely, long-term safety data is genuinely needed.
Comparison to active comparators: Most trials compare ashwagandha to placebo. Head-to-head comparisons with established sleep interventions (melatonin, cognitive behavioral therapy for insomnia, or prescription medications) would help clinicians and patients understand where ashwagandha fits in the treatment landscape.
Optimal formulation: The ashwagandha triethylene glycol sleep research raises the question of whether leaf-based or specifically TEG-enriched extracts would outperform the root extracts used in most clinical trials. This is an underexplored area.
Pediatric and elderly populations: Essentially all clinical sleep research has been conducted in working-age adults. Data in older adults with age-related sleep changes, or in children and adolescents, is lacking.
Mechanistic clinical studies: While we have plausible mechanisms (cortisol reduction, GABAergic modulation, TEG-induced NREM enhancement), human studies that directly measure the proposed mechanisms alongside sleep outcomes — to confirm causality rather than just correlation — would strengthen the field considerably.
Frequently Asked Questions
Does ashwagandha actually improve sleep quality?
Based on the current clinical evidence, yes — with important caveats. The 2021 PLOS One meta-analysis of five RCTs involving 400 participants found a statistically significant and clinically meaningful improvement in sleep quality (SMD -0.59, p < 0.001) compared to placebo. The NIH's Office of Dietary Supplements has also acknowledged that clinical trials have found improvements in sleep quality, efficiency, total sleep time, and sleep latency. The effects are real but moderate, and they are most pronounced in people with existing sleep problems.
What dose is supported by clinical research?
The dose with the strongest evidence base is 600 mg/day of standardized root extract, used consistently in the majority of trials showing positive effects. This is often split into two 300 mg doses. Lower doses (below 300 mg/day) have less evidence, and there isn't strong data showing that doses above 600 mg/day produce proportionally better results.
How long does ashwagandha take to work for sleep?
Clinical research suggests the most significant benefits appear with at least 8 weeks of consistent use. Some improvement may be noticed earlier, but trials consistently show larger effect sizes at the 8-week mark and beyond. This is consistent with the proposed mechanism of HPA axis rebalancing and cortisol normalization, which is a gradual process.
Is ashwagandha better for people with insomnia than healthy sleepers?
Yes, clearly. The 2021 meta-analysis found subgroup differences showing stronger effects in people with insomnia, and individual trials including both insomnia and healthy subjects have found greater improvements in the insomnia group. Healthy sleepers may still experience modest benefits, but the effect size is smaller.
What specific sleep outcomes improve?
The clinical literature shows improvements in: subjective sleep quality scores (PSQI), sleep onset latency (time to fall asleep), total sleep time, sleep efficiency (ratio of sleep to time in bed), and daytime functioning. Some evidence also points to improvements in slow-wave (deep) sleep, though this needs more large-scale objective data.
Does ashwagandha help sleep by reducing stress and anxiety?
This appears to be a primary mechanism. Ashwagandha consistently reduces serum cortisol levels in clinical trials — by approximately 27–30% in some studies — which helps normalize the evening cortisol decline that allows deep sleep to occur. It also has well-documented anxiolytic effects. For people whose sleep problems are driven by stress and anxiety (a large proportion of insomnia cases), this stress-reducing mechanism is likely central to the benefit.
Is ashwagandha safe for sleep use?
At 600 mg/day for up to 8–12 weeks, ashwagandha appears generally well tolerated in healthy adults. Common side effects are mild GI symptoms. Rare but serious hepatotoxicity (liver injury) cases have been reported and should be taken seriously. Pregnant women, people with autoimmune conditions, thyroid disorders, or those taking immunosuppressants, thyroid medications, or sedatives should consult a physician before use.
Is there randomized controlled trial evidence, or only reviews?
There are multiple randomized controlled trials (RCTs). The 2021 meta-analysis pooled five RCTs. Individual double-blind, placebo-controlled trials — including the frequently cited 2020/2021 study using KSM-66 extract — form the primary evidence base. The reviews and meta-analyses synthesize these trials rather than substituting for them.
Are there studies in both healthy adults and people with insomnia?
Yes. Some trials enrolled specifically insomnia populations; others enrolled healthy adults. A few trials enrolled both groups and directly compared the effects, consistently finding greater improvements in the insomnia subgroup. There is also an ongoing trial in healthy college students that will add to the healthy population data when published.
Can I take ashwagandha with melatonin or other sleep supplements?
The research does not specifically address combinations. Mechanistically, ashwagandha and melatonin work through different pathways (HPA axis/cortisol regulation vs. circadian signaling), so they may be complementary. However, combining ashwagandha with any sedating supplement or medication requires caution due to potential additive sedative effects. Consult a healthcare provider about any combination use.
Support Your Stress Response, Lower Cortisol and Feel Calmer, Clearer and More Like Yourself Again.
Try our new organic cortisol balance drops risk free
Shop Organic Cortisol Balance DropsBottom Line
The ashwagandha sleep quality clinical research as of 2025 supports several reasonably confident conclusions — and is honest about what remains uncertain.
What the Evidence Supports
Ashwagandha improves sleep quality in a clinically meaningful way compared to placebo, with the strongest evidence coming from a 2021 meta-analysis of five RCTs involving 400 people (SMD -0.59, p < 0.001). Specific outcomes that improve include sleep quality scores, sleep onset latency, total sleep time, sleep efficiency, and daytime functioning.
The effects are most pronounced in people with insomnia and those experiencing stress-related sleep disruption, where the cortisol-normalizing and anxiolytic mechanisms are most relevant.
600 mg/day for at least 8 weeks appears to be the dose-duration combination with the best clinical support. This is not a fast-acting remedy — it's a gradual, cumulative intervention.
KSM-66 is the most studied extract, with consistent double-blind RCT evidence behind it. When evaluating products, standardized extracts with specified withanolide content provide more reliability than unstandardized powders.
The mechanism likely involves cortisol reduction, GABAergic modulation, and — particularly regarding deep sleep — the compound triethylene glycol, which preclinical research suggests specifically promotes NREM slow-wave sleep.
What the Evidence Doesn't Yet Fully Establish
Long-term safety data beyond 12 weeks is limited. Objective polysomnographic data is sparse. Direct comparisons with established sleep interventions (CBT-I, pharmaceutical options) don't yet exist. Effects in populations outside working-age adults are poorly characterized.
How to Think About It
Ashwagandha is not a replacement for cognitive behavioral therapy for insomnia (CBT-I), which remains the gold standard first-line treatment for chronic insomnia disorder. It is not a pharmaceutical hypnotic and should not be expected to produce dramatic, immediate sedation. What the clinical evidence supports is a moderate, real, gradually developing improvement in sleep quality — particularly for stressed adults, those with stress-related insomnia, and people seeking a non-pharmaceutical option to address the physiological underpinnings of their sleep problems.
For anyone considering ashwagandha for sleep, the research-supported approach is clear: use a standardized extract (KSM-66 has the most clinical backing), at 600 mg/day, for at least 8 weeks, and evaluate results at that time horizon rather than after a few days. And as with any supplement, particularly one with potential hormonal and hepatic effects, a conversation with a healthcare provider is worthwhile before starting — especially for those with pre-existing medical conditions or who take medications.
The withania somnifera sleep research is still evolving, but the current evidence is more than sufficient to call it a legitimate, evidence-supported option in the landscape of sleep-supportive interventions. That's a more meaningful statement than it might sound — most supplements making sleep claims don't have a single RCT behind them, let alone a meta-analysis of five.
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any supplement, particularly if you have a medical condition, take medications, or are pregnant or breastfeeding.
Sources Referenced:
- Randomized controlled trial on ashwagandha extract in insomnia and healthy subjects (2020/2021, PubMed)
- PLOS One meta-analysis of ashwagandha and sleep (2021) — DOI: 10.1371/journal.pone.0257843
- Clinical review of double-blind placebo-controlled ashwagandha sleep trials
- NIH Office of Dietary Supplements — Ashwagandha Fact Sheet for Health Professionals
- Sleep Foundation — Ashwagandha and Sleep
- ClinicalTrials.gov — Ongoing study on 700 mg/day ashwagandha in college students
0 comments